A new study led by investigators from Mass General Brigham has identified a unique brain network that links varied patterns of brain atrophy, or shrinkage, associated with schizophrenia.
The Institute of Cancer Research, London, is the second-ranked academic research centre in the UK - according to the Times Higher Education league table of university research quality and impact ...
At a time when fundamental questions are being posed about medical science, writes Jennifer Handt, let us not forget the beauty of it, the existential poetry and shared humanity that drives us toward ...
ADELA, an international phase III study being conducted across multiple countries, combines elacestrant with everolimus to treat advanced ER+/HER2- breast cancer with ESR1 mutations, aiming to delay ...
AstraZeneca and MSD's PARP inhibitor Lynparza has improved long-term survival when given as adjuvant therapy for early breast ...
The federal Food & Drug Administration has approved two new Alzheimer’s medications that can offer people more time to live ...
An investigation published by The BMJ today raises new concerns over the landmark clinical trial (PLATO) that was used to gain worldwide approval for the anti-platelet drug ticagrelor (Brilinta in the ...
The highly anticipated PROSPECT-Lung trial has officially opened, marking a significant step forward in the quest to improve treatment strategies for patients with resectable non-small cell lung ...
A new clinical study being done at UCSF could change the way doctors treat patients with traumatic brain injuries.
FemPulse announced today that it received FDA investigational device exemption (IDE) approval for its overactive bladder (OAB ...
Kyverna Therapeutics was sued by an investor that lost money from stock that has fallen almost 80% since its February IPO.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback